{"schema_version":"1","generated_at":"2026-11-08T01:41:23.491Z","data_as_of":null,"url":"https://www.findmykol.com/kol/rodrigo-maegawa","json_url":"https://www.findmykol.com/kol/rodrigo-maegawa/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"rodrigo-maegawa","name":"Rodrigo Maegawa","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Janssen Scientific Affairs","institution_url":"https://www.findmykol.com/institution/janssen-scientific-affairs","city":"Atlanta","state":"GA","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1518131168","openalex":"A5018004262"},"summary":"Rodrigo Maegawa is an Oncology physician affiliated with Janssen Scientific Affairs. OpenAlex indexes 44 publications with 469 citations (h-index 10).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":44,"cited_by_count":469,"h_index":10,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":2,"shown":2,"withheld":0,"rows":[{"payer":"Gilead Sciences, Inc.","program_year":2025,"amount_usd":55.59,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1518131168"},{"payer":"Incyte Corporation","program_year":2025,"amount_usd":24.12,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1518131168"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1518131168","source":"payments"},"publications":{"total":44,"shown":5,"withheld":39,"matched_by":"OpenAlex author record","recent":[{"title":"CLL-481 Ibrutinib Efficacy Across Subgroups of Patients With High-Risk Chronic Lymphocytic Leukemia: A Systematic Literature Review","year":2024,"journal":"Clinical Lymphoma Myeloma & Leukemia","source_url":"https://doi.org/10.1016/s2152-2650(24)01285-0","status":"verified"},{"title":"Ibrutinib Efficacy Across Subgroups of Patients With High-Risk Chronic Lymphocytic Leukemia: A Systematic Literature Review","year":2024,"journal":"Clinical Lymphoma Myeloma & Leukemia","source_url":"https://doi.org/10.1016/s2152-2650(24)00589-5","status":"verified"},{"title":"Comparison of Time to Next Treatment Between Patients With Chronic Lymphocytic Leukemia Initiating First-Line Ibrutinib or Acalabrutinib Overall and in a Subgroup With High-Risk Characteristics","year":2024,"journal":"Clinical Lymphoma Myeloma & Leukemia","source_url":"https://doi.org/10.1016/s2152-2650(24)00581-0","status":"verified"},{"title":"CLL-342 Comparison of Time to Next Treatment Between Patients With Chronic Lymphocytic Leukemia Initiating First-Line Ibrutinib or Acalabrutinib Overall and in a Subgroup With High-Risk Characteristics","year":2024,"journal":"Clinical Lymphoma Myeloma & Leukemia","source_url":"https://doi.org/10.1016/s2152-2650(24)01275-8","status":"verified"},{"title":"Molecular response in newly diagnosed chronic-phase chronic myeloid leukemia: prediction modeling and pathway analysis","year":2023,"journal":"Haematologica","source_url":"https://doi.org/10.3324/haematol.2022.281878","status":"verified"}],"source":"works"},"contact":{"address_1":"5670 PEACHTREE DUNWOODY RD STE 990A","city":"Atlanta","state":"GA","zip":"303424790","phone":"404-303-4307","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1518131168","source":"identity"},"similar":[{"name":"Samir H. Mody","slug":"samir-mody","institution":"Janssen Scientific Affairs","url":"https://www.findmykol.com/kol/samir-mody","json_url":"https://www.findmykol.com/kol/samir-mody/profile.json"},{"name":"Martin Ryser","slug":"martin-ryser","institution":"Janssen Scientific Affairs","url":"https://www.findmykol.com/kol/martin-ryser","json_url":"https://www.findmykol.com/kol/martin-ryser/profile.json"},{"name":"Michelle L. Kramer","slug":"michelle-kramer","institution":"Janssen Scientific Affairs","url":"https://www.findmykol.com/kol/michelle-kramer","json_url":"https://www.findmykol.com/kol/michelle-kramer/profile.json"},{"name":"Riad D Dirani","slug":"riad-dirani","institution":"Janssen Scientific Affairs","url":"https://www.findmykol.com/kol/riad-dirani","json_url":"https://www.findmykol.com/kol/riad-dirani/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":39}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2025-10-07","provider_certified":"2025-10-07","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}